172 related articles for article (PubMed ID: 28767722)
1. Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania.
Ngalesoni F; Ruhago G; Mayige M; Oliveira TC; Robberstad B; Norheim OF; Higashi H
PLoS One; 2017; 12(8):e0182113. PubMed ID: 28767722
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
[TBL] [Abstract][Full Text] [Related]
3. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ortegón M; Lim S; Chisholm D; Mendis S
BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
[TBL] [Abstract][Full Text] [Related]
5. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Population-Based Tobacco Control Interventions on the Health Burden of Cardiovascular Diseases in Vietnam.
Nguyen DT; Luong KN; Phan HT; Tran AT; Dao ST; Poudel AN; Hoang TM; Do VV; Le DM; Pham GH; Nguyen LT; Duong AT; Hoang MV
Asia Pac J Public Health; 2021 Nov; 33(8):854-860. PubMed ID: 33764194
[TBL] [Abstract][Full Text] [Related]
7. Community-based youth tobacco control interventions: cost effectiveness of the Full Court Press project.
Ross H; Powell LM; Bauer JE; Levy DT; Peck RM; Lee HR
Appl Health Econ Health Policy; 2006; 5(3):167-76. PubMed ID: 17132031
[TBL] [Abstract][Full Text] [Related]
8. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
[TBL] [Abstract][Full Text] [Related]
10. Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
Cadier B; Durand-Zaleski I; Thomas D; Chevreul K
PLoS One; 2016; 11(2):e0148750. PubMed ID: 26909802
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
[TBL] [Abstract][Full Text] [Related]
12. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of a school-based smoking prevention program in India.
Brown HS; Stigler M; Perry C; Dhavan P; Arora M; Reddy KS
Health Promot Int; 2013 Jun; 28(2):178-86. PubMed ID: 22271928
[TBL] [Abstract][Full Text] [Related]
14. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
[TBL] [Abstract][Full Text] [Related]
15. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A
Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
[TBL] [Abstract][Full Text] [Related]
16. Are Office-Based Workplace Interventions Designed to Reduce Sitting Time Cost-Effective Primary Prevention Measures for Cardiovascular Disease? A Systematic Review and Modelled Economic Evaluation.
Gao L; Nguyen P; Dunstan D; Moodie M
Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30866495
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.
Webb M; Fahimi S; Singh GM; Khatibzadeh S; Micha R; Powles J; Mozaffarian D
BMJ; 2017 Jan; 356():i6699. PubMed ID: 28073749
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease.
Michaud TL; Abraham J; Jalal H; Luepker RV; Duval S; Hirsch AT
J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702086
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of a theory-based online health behaviour intervention for new university students: an economic evaluation.
Kruger J; Brennan A; Strong M; Thomas C; Norman P; Epton T
BMC Public Health; 2014 Sep; 14():1011. PubMed ID: 25262372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]